Investment Plans


SUMMARY OF THE COMPANY'S INVESTMENT PLANS & EXPANSION PROJECTS

The following table summarizes the main investments implemented since 2002:

LAVIPHARM SA INVESTMENTS 2002-2004
Most important achieved investments (amounts in euro)

 

 

2002

2003

2004

TYPE OF INVESTMENT

 

 

 

REPURCHASE OF FOREIGN AFFILIATED COMPANIES SHARE

0,00

0,00

480.000,00

REPURCHASE OF DOMESTIC AFFILIATED COMPANIES SHARE

0,00

0,00

2.800.000,00

ESTABLISHMENT OF DOMESTIC COMPANY

0,00

0,00

53.700,00

INCREASE IN THE CAPITAL OF AFFILIATED COMPANIES

2.964.076,64

9.991.500,00

0,00

INTANGIBLE ASSETS

R & D EXPENSES

818.892,59

1.180.716,68

879.986,76

PATENTS & LICENSES

17.649.353,87

6.870.221,04

6.900.167,66

TOTAL

18.468.246,46

8.050.937,72

7.780.154,42

TANGIBLE ASSETS

LAND DEVELOPMENT

1.194.920,00

0,00

0,00

BUILDINGS & PLANTS

426.704,90

459.635,83

467.381,48

MACHINERY & OTHER TECHNICAL INSTALLATIONS

317.995,65

171.784,61

200.714,28

TRANSPORTATION EQUIPMENT

0,00

0,00

23.120,68

FURNITURE & OTHER OFFICE EQUIPMENT

161.373,62

133.208,50

63.191,35

TOTAL

2.100.994,17

764.628,94

754.407,79

TOTAL INVESTMENTS

23.533.317,27

18.807.066,66

11.868.262,21




 

 

 

 

 

 

 

 

 

 


It is worth noting that as part of its drive for growth, the Lavipharm Group keeps developing new strategies for the following years, while at the same time exploring and studying new cooperation schemes for its future growth and expansion, both in Greece and internationally.



Investor relations
Share
Financial Information
Annual Reports-Presentations
  Calendar of Events
  Investment Risks
Investment Plans
  Share Capital History
  Press Releases
  Contact
Return to main page Ελληνική έκδοση Return to main page USA